Potent casesin kinase 1δ/ε inhibitor (IC50 values are 3.9 and 17 nM, respectively). Mediates circadian rhythm phase-delaying effects in vivo. Attenuates opioid drug seeking behaviour in addiction in vivo models.
Sold for research purposes under agreement from Pfizer Inc.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 419.46. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.38 mL||11.92 mL||23.84 mL|
|5 mM||0.48 mL||2.38 mL||4.77 mL|
|10 mM||0.24 mL||1.19 mL||2.38 mL|
|50 mM||0.05 mL||0.24 mL||0.48 mL|
References are publications that support the products' biological activity.
Wager et al (2014) Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior. ACS Chem.Neurosci. 5 1253 PMID: 25299732
If you know of a relevant reference for PF 5006739, please let us know.
View Related Products by Product Action
Keywords: PF 5006739, supplier, PF5006739, Casesin, kinase, 1δ/ε, delta, epsilon, inhibitors, inhibits, circadian, rhythm, opioid, drug, seeking, behaviour, addiction, Casein, Kinase, 1, Casein, Kinase, 1, Tocris Bioscience
Citations for PF 5006739
Citations are publications that use Tocris products.
Currently there are no citations for PF 5006739. Do you know of a great paper that uses PF 5006739 from Tocris? If so please let us know.
PF 5006739 Reviews
Average Rating:(Based on 0 Reviews)